Back
Trevi Therapeutics Vs. Vanda Pharmaceuticals Industry Stock Comparison
Buy
69
TRVI
Trevi Therapeutics
Last Price:
2.76
Seasonality Move:
50.69%
Buy
56
VNDA
Vanda Pharmaceuticals
Last Price:
5.49
Seasonality Move:
5.49%
Buy
69
Trevi Therapeutics (TRVI)
is a Buy
Is Trevi Therapeutics a Buy, Sell or Hold?
- The current Trevi Therapeutics [TRVI] share price is $2.77. The Score for TRVI is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- TRVI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Vanda Pharmaceuticals (VNDA)
is a Buy
Is Vanda Pharmaceuticals a Buy, Sell or Hold?
- The current Vanda Pharmaceuticals [VNDA] share price is $5.48. The Score for VNDA is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- VNDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TRVI Stock Price Chart
What is Trevi Therapeutics's stock price today?
-
The Trevi Therapeutics share price today is $2.77
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRVI is experiencing selling pressure, which indicates risk of future bearish movement.
VNDA Stock Price Chart
What is Vanda Pharmaceuticals's stock price today?
-
The Vanda Pharmaceuticals share price today is $5.48
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VNDA is experiencing selling pressure, which indicates risk of future bearish movement.
TRVI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 47.35 | Sell |
| Chaikin Money Flow: | -52084 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.68 - 2.94) | Sell |
| Bollinger Bands (100): | (1.67 - 3.19) | Buy |
VNDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.25 | Buy |
| Relative Strength Index (14 RSI): | 62.7 | Buy |
| Chaikin Money Flow: | -716416 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.52 - 5.3) | Buy |
| Bollinger Bands (100): | (3.78 - 4.78) | Buy |
TRVI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.79 | Sell |
| 20-day SMA: | 2.84 | Sell |
| 50-day SMA: | 3 | Sell |
| 200-day SMA: | 2.12 | Buy |
| 8-day EMA: | 2.81 | Sell |
| 20-day EMA: | 2.84 | Sell |
| 50-day EMA: | 2.8 | Sell |
| 200-day EMA: | 2.35 | Buy |
VNDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.25 | Buy |
| 20-day SMA: | 4.97 | Buy |
| 50-day SMA: | 4.5 | Buy |
| 200-day SMA: | 4.39 | Buy |
| 8-day EMA: | 5.28 | Buy |
| 20-day EMA: | 5.03 | Buy |
| 50-day EMA: | 4.68 | Buy |
| 200-day EMA: | 4.79 | Buy |
Trevi Therapeutics Earnings Growth & TRVI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.08 per share.
Vanda Pharmaceuticals Earnings Growth & VNDA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Trevi Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vanda Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||